drugset / Trial / NCT01919554
Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts in Adolescents
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to investigate the safety and tolerability of different doses of sublingual tablets of house dust mite (HDM) allergen extracts in adolescents with house dust mite-associated allergic rhinitis.
Timeline
- Start
- 2013-07
- Primary completion
- 2013-09
- Completion
- 2013-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | house dust mites allergen extract | Other / unclassified | 500 unknown | Other |
| Subject | house dust mites allergen extract | Other / unclassified | 1000 unknown | Other |
| Subject | house dust mites allergen extract | Other / unclassified | 1500 unknown | Other |